Product Information
LOFENA 25 MG TABLET is a generic product labeled by CarWin Pharmaceutical Associates LLC, priced at $4.5668 per EA under NDC 15370018060. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Mar 18, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
CarWin Pharmaceutical Associates LLCNDC
15370018060
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DICLOFENAC POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA076561FDA Approved
3/18/2004
TE Code
AB
On Market Since
10/25/2021
Pharmacological Classes
Price Statistics
The NADAC for LOFENA 25 MG TABLET has been published 129 times since Apr 17, 2024, and over the history we have for it it has declined 77.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.5668 per EA |
|---|---|
| All-time high | $20.1948 (May 15, 2024) |
| All-time low | $3.7164 (Mar 18, 2026) |
| 52-week high | $10.8997 |
| 52-week low | $3.7164 |
| Median price | $11.6858 |
| Average price | $10.6619 |
| Largest weekly change | -28.3% (Nov 19, 2025) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
CarWin Pharmaceutical Associates LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DICLOFENAC POTASSIUM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LOFENA 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LOFENA 25 MG TABLET, manufactured by CarWin Pharmaceutical Associates LLC, is $4.5668 per EA (NDC 15370018060), effective Sep 30, 2026.
How has the price of LOFENA 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for LOFENA 25 MG TABLET has declined 77.4%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for LOFENA 25 MG TABLET?
Since Apr 17, 2024, the NADAC for LOFENA 25 MG TABLET has ranged from a low of $3.7164 (Mar 18, 2026) to a high of $20.1948 (May 15, 2024), with a median of $11.6858 per EA.
Are there cheaper alternatives to LOFENA 25 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LOFENA 25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LOFENA 25 MG TABLET?
LOFENA 25 MG TABLET (NDC 15370018060) is labeled by CarWin Pharmaceutical Associates LLC, and CMS classifies it as a generic product.